No Detail Found!

The Relationship between Hormonal Contraception and Breast Cancer

Author(s)
Adel Mahjoub Musa Mohamed Hafr Elbaten Central hospital,Hafr Elbaten,Saudi Arabia
Fatimah Khalifah Ayed Alshammari Northern Border University, Arar, Saudi A rabia.
Razan Fahad Saleh Alotayfi Northern Border University, Arar, Saudi A rabia.
Khawlah Hameed Mamlooh Alenazi Northern Border University, Arar, Saudi A rabia.
Amjad Mofareh S Alruwaili Northern Border University, Arar, Saudi A rabia.
Abstract
Breast cancer is the most common cancer among women in the world and has become a growing important problem in lowand middle-income countries. Different patient variables have been reported for their association with breast cancer over time, including family background, age, sex, breast mass, monarchal age, contraception use, diet, physical inactivity, and obesity among others. Contraceptive pills are the most commonly prescribed method of birth control and account for 13% of the 140 million consumers worldwide. Data indicate that OC use for a long duration can increase breast cancer risk in women below 45 years of age. Method: This systematic review was carried out, including PubMed, Google Scholar, and EBSCO. Topics regarding the relationship between breast cancer and hormonal contraceptives and other articles were used in making the article. The found articles were screened by titles and reviewing the abstracts. Results and Conclusion: The review included 11 randomized studies that discussed the relationship between breast cancer and hormonal contraceptives. Although hormone is an efficient way of contraception, many studies have reported a potential risk of BC. The risk of breast cancer should be balanced against the benefits of using hormonal contraceptives. Awareness about breast cancer self-examination is very necessary and should be raised among hormonal contraceptive users, so women do it correctly.
Publication Details
Page(s) 124-129
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
Relationship, Women, Breast Cancer, Breast Malignancy, Hormonal contraception, Contraceptive Pills
References
Hunter .2010 .. , : .
Cibula .2010 .. , : .
Dumeaux . .. , 27 : .
Schneyer ,Lerma .2018 .. , : .
Pragout ,Jemal A,Thomas A,Murray T,Thun M .2002 .. 2002 Jan, 1(1) : 23-47.
Samir D,Naouel A,Safa G .2019 .Assessment of Hematological Parameters, Enzymes Activities, and Oxidative Stress Markers in Salivary and Blood of Algerian Breast Cancer Patients Receiving Chemotherapy. Journal of Biochemical Technology, 10(4) : 50.
Diab M,Shaker O,Nassar Y,Abd El-Aziz G,El-Marzoki M .2018 .Expression of Her2 and Topo II Alpha in breast cancer. Journal of Advanced Pharmacy Education & Research| Apr-Jun, 8(2) : .
Anders CK,Johnson R,Litton J,Phillips M,Bleyer A . .Breast cancer before age 40 years. InSeminars in oncology 2009 Jun, 36(3) : 237-249.
. .Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. The Lancet. 1996 Jun, 347(9017) : 1713-27.
Amadou A,Fabre A,Torres-Mejía G,Ortega-Olvera C,AngelesLlerenas A,McKenzie F,Biessy C,Hainaut P,Romieu I. . .Hormonal therapy and risk of breast cancer in Mexican women. 2013 Nov, 15(11) : e79695.
Boyd NF,Melnichouk O,Martin LJ,Hislop G,Chiarelli AM,Yaffe MJ,Minkin S. . .Mammographic density, response to hormones, and breast cancer risk. J Clin Oncol. 2011 Aug, 1(22) : 2985-92.
de Bastos M,Stegeman BH,Rosendaal FR,Vlieg AV,Helmerhorst FM,Stijnen T,Dekkers OM .2014 .Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews, 3 : .
Schindler AE .2013 .Non-contraceptive benefits of oral hormonal contraceptives. International journal of endocrinology and metabolism, 11(1) : 41.
Gonzalez R,Reingold BK,Gao X,Gaidhu MP,Tsushima RG,Unniappan S . .Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β-and MIN6 cells. 2011 Mar, 1(3) : R9-16.
Zhu H,Lei X,Feng J,Wang Y . .Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies. The European Journal of Contraception & Reproductive Health Care. 2012 Dec, 1(6) : 402-14.
Moorman PG,Havrilesky LJ,Gierisch JM,Coeytaux RR,Lowery WJ,Peragallo Urrutia R,Dinan M,McBroom AJ,Hasselblad V,Sanders GD,Myers ER . .Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. 2013 Nov, 31(33) : 4188-98.
Malone KE,Daling JR,Weiss NS .1993 .Oral contraceptives in relation to breast cancer. Epidemiologic reviews, 8405215(1) : 80.
. .Hormonal birth control - whether it comes as pills, injections, a ring, an intrauterine device (IUD), or an implant - may raise your risk of breast cancer, according to a study published Dec. 7, 2017. , : .
White ND . .Published 2018 Jan 31. 2018 May;12, 10(3) : 224-6.
IARC. Combined .2007 .. , : .
Gierisch JM,Coeytaux RR,Urrutia RP,Havrilesky LJ,Moorman PG,Lowery WJ,Dinan M,McBroom AJ,Hasselblad V,Sanders GD,Myers ER . .Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. 2013 Nov, 1(11) : 1931-43.
Dorchak JA,Maria S,Guarinoni JL,Duensing A,Somiari S,Cavanaugh J,Deyarmin B,Hu H,Iida J,Shriver CD,Witt-Enderby PA . .. 2018 Aug, 10(4) : 240-53.
Layde PM,Webster LA,Baughman AL,Wingo PA,Rubin GL,Ory HW . .The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. 1989 Jan, 1(10) : 963-73.
Bardaweel SK,Akour AA,Al-Muhaissen S,AlSalamat HA,Ammar K. . .Published 2019 Jun 3. 2019 Dec, 10(1) : 72.
Ji LW,Jing CX,Zhuang SL,Pan WC,Hu XP .2019 .Effect of age at first use of oral contraceptives on breast cancer risk: An updated metaanalysis. Medicine (Baltimore), 10(36) : .
Hunter DJ,Colditz GA,Hankinson SE,Malspeis S,Spiegelman D,Chen W,Stampfer MJ,Willett WC . .Oral contraceptive use and breast cancer: a prospective study of young women. 2010 Oct, 10(10) : 1055-9965.
Beral V . .Breast cancer and hormonal contraceptives: further results. doi:10.1016/s0010- 7824, 5(15) : 30002-0.
Pragout D,Laurence V,Baffet H,Raccah-Tebeka B,RoussetJablonski C. B .2018 .Contraception et cancer. RPC Contraception CNGOF. Gynécologie Obstétrique Fertilité & Sénologie. 2018 Dec, 10(12) : 834-44.
Chaveepojnkamjorn W,Pichainarong N,Thotong R,Sativipawee P,Pitikultang S. .2017 .Published 2017 May 1. Asian Pacific journal of cancer prevention: APJCP, 18(5) : 1429.
Cibula D,Gompel A,Mueck AO,La Vecchia C,Hannaford PC,Skouby SO,Zikan M,Dusek L M . .Hormonal contraception and risk of cancer. 2010 Nov, 10(6) : 631-50.
Dumeaux V,Fournier A,Lund E,Clavel-Chapelon F E .2005 .Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control, 10(5) : 537-544.
Schneyer R,Lerma K. .2018 .Health outcomes associated with use of hormonal contraception: breast cancer. Curr Opin Obstet Gynecol, 10(6) : 414-418.
Khalis M,El Rhazi K,Charaka H,Chajès V,Rinaldi S,Nejjari C,Romieu I,Charbotel B .2016 .Published 2016 Dec 1. Asian Pacific Journal of Cancer Prevention: Apjcp, 17(12) : 5211.
.2012 .Globocan 2012:Country fast stat. , : 1-7.
Lee JR .2008 .. Trans Dina Indra Safitri, : .
Abdel-Sattar SA,Ibrahim HA,El HA . .. Int. J. Pharm. Res. Allied Sci. 2018 Jan, 1(3) : 198-208.
Abdallah NM,Eldin SA,Gad AH .2018 .Breast and nipple problems encountered among puerperal primipara women in Zagazig. Int. J. Pharm. Res. Allied Sci, 7(1) : 183-95.
Mørch LS,Skovlund CW,Hannaford PC,Iversen L,Fielding S,Lidegaard Ø . .Contemporary Hormonal Contraception and the Risk of Breast Cancer. 2017 Dec, 29211679(23) : 2228-2239.
Marchbanks PA,McDonald JA,Wilson HG,Folger SG,Mandel MG,Daling JR,Bernstein L,Malone KE,Ursin G,Strom BL,Norman SA . .Oral contraceptives and the risk of breast cancer. 2002 Jun, 346(26) : 2025-32.
Soroush A,Farshchian N,Komasi S,Izadi N,Amirifard N,Shahmohammadi A . .The role of oral contraceptive pills on increased risk of breast cancer in Iranian populations: a meta-analysis. 2016 Dec;21, (4) : 294.
Rosenberg L,Zhang Y,Coogan PF,Strom BL,Palmer JR . .A casecontrol study of oral contraceptive use and incident breast cancer. 2009 Feb, 15(4) : 473-9.
Hemminki E,Luostarinen T,Pukkala E,Apter D,Hakulinen T. . .Oral contraceptive use before first birth and risk of breast cancer: a case control study. BMC women's health. 2002 Dec, 1(1) : 9.
Nyante SJ,Gammon MD,Malone KE,Daling JR,Brinton LA . .The association between oral contraceptive use and lobular and ductal breast cancer in young women. 2008 Feb, 15(4) : 936-41.
Kahlenborn C,Modugno F,Potter DM,Severs WB . .Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. InMayo Clinic Proceedings 2006 Oct, 10 : 1290-1302.
Newcomer LM,Newcomb PA,Trentham‐Dietz A,Longnecker MP,Greenberg ER . .Oral contraceptive use and risk of breast cancer by histologic type. 2003 Oct, 10(6) : 961-4.
Grabrick DM,Hartmann LC,Cerhan JR,Vierkant RA,Therneau TM,Vachon CM,Olson JE,Couch FJ,Anderson KE,Pankratz VS,Sellers TA . .Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. Jama. 2000 Oct, 284(14) : 1791-8.
Wingo PA,Lee NC,Ory HW,Beral V,Peterson HB,Rhodes P .1993 .Agespecific differences in the relationship between oral contraceptive use and breast cancer. Cancer, 71(suppl) : 1506-1517.
Althuis MD,Brogan DD,Coates RJ,Daling JR,Gammon MD,Malone KE,Schoenberg JB,Brinton LA . .Breast cancers among very young premenopausal women (United States). Cancer Causes & Control. 2003 Mar, 1(2) : 151-60.
Althuis MD,Brogan DR,Coates RJ,Daling JR,Gammon MD,Malone KE,Schoenberg JB,Brinton LA . .Hormonal content and potency of oral contraceptives and breast cancer risk among young women. British journal of cancer, 88(1) : 50-7.
Li L,Zhong Y,Zhang H,Yu H,Huang Y,Li Z,Chen G,Hua X . .Association between oral contraceptive use as a risk factor and triplenegative breast cancer: A systematic review and meta-analysis. 2017 Jul, 1(1) : 76-80.
Dolle JM,Daling JR,White E,Brinton LA,Doody DR,Porter PL,Malone KE,Biomarkers Prevention . .Risk factors for triple-negative breast cancer in women under the age of 45 years. 2009 Apr, 1(4) : 1157-66.
Phipps AI,Chlebowski RT,Prentice R,McTiernan A,WactawskiWende J,Kuller LH,Adams-Campbell LL,Lane D,Stefanick ML,Vitolins M,Kabat GC . .Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. 2011 Mar, 16(6) : 470-7.
Haile RW,Thomas DC,McGuire V,Felberg A,John EM,Milne RL,Hopper JL,Jenkins MA,Levine AJ,Daly MM,Buys SS,Biomarkers Prevention . .BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. 2006 Oct, 1(10) : 1863-70.
Silvera SA,Miller AB,Rohan TE .2005 .Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer:a prospective cohort study. Cancer Causes Control, 16(9) : 1059-63.
Milne RL,Knight JA,John EM,Dite GS,Balbuena R,Ziogas A,Andrulis IL,West DW,Li FP,Southey MC,Giles GG . .Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. 2005 Feb, 1(2) : 350-6.
Jernström H,Loman N,Johannsson OT,Borg Å,Olsson H . .Impact of teenage oral contraceptive use in a population-based series of earlyonset breast cancer cases who have undergone BRCA mutation testing. 2005 Oct, 1(15) : 2312-20.
Van Hoften C,Burger H,Peeters PH,Grobbee DE,Van Noord PA,Leufkens HG . .Long‐term oral contraceptive use increases breast cancer risk in women over 55 years of age: The DOM cohort. 2000 Aug, 15(4) : 591-4.
Tessaro S,Béria JU,Tomasi E,Barros AJ .2001 .. , 35 : 32-8.
0

Citations

0

Downloads

14

Views